In contrast to general health and wellness apps, a new category of digital therapies is emerging to prevent, manage, and even treat medical conditions. Regardless of their clinical claims, all digital therapeutics must be evidence-based and adhere to quality, security, and usability standards. Digital therapies are being developed to address a wide range of conditions, from diabetes and asthma, to depression and opioid addiction. But where do these fit in terms of managed care access and reimbursement?
- Benjamin Parcher
Assistant Director, Strategic Market Access and Intelligence
- Caroline Popper
Popper and Company
Co-Founder and President